SER serinatherapeutics.com: שווי נכסים נקי

Serina Therapeutics, Inc. (SER) develops advanced polymer systems for the direct transport of medications to the brain, overcoming biological barriers in Alzheimer's therapy. The price indicator on the chart, with a value of 0.02, accompanies the development of a line of long-acting treatments for Parkinson's disease. However, business success relies on the safety of the POZ method and the reduction of treatment toxicity during clinical trials.

Book value capitalization represents the difference between total assets and liabilities, reflecting the actual value of equity. By analyzing the total book capitalization at 0.02, an investor sees the net business value stripped of borrowed funds. For Serina Therapeutics, Inc. (SER), this metric demonstrates financial stability while developing a breakthrough polymer drug delivery platform for Parkinson's disease therapy.